# An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

> **NCT02889302** · PHASE3 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 203 (actual)

## Conditions studied

- Spinocerebellar Degeneration

## Interventions

- **DRUG:** KPS-0373
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02889302
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-15
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2018-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02889302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02889302, "An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02889302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*